Patents by Inventor Larry Cameron Anthony

Larry Cameron Anthony has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120252084
    Abstract: A high flux in conversion of pyruvate to acetolactate was achieved in yeast through expression of acetolactate synthase in the cytosol in conjunction with reduction in pyruvate decarboxylase activity. Additional manipulations to improve flux to acetolactate are reduced pyruvate dehydrogenase activity and reduced glycerol-3-phosphate dehydrogenase activity. Production of compounds having acetolactate as an upstream intermediate benefit from the increased conversion of pruvate to acetolactate in the described strains.
    Type: Application
    Filed: November 18, 2011
    Publication date: October 4, 2012
    Inventors: Larry Cameron ANTHONY, Lori Ann Maggio-Hall
  • Publication number: 20120237988
    Abstract: The invention relates to recombinant host cells having at least one integrated polynucleotide encoding a polypeptide that catalyzes a step in a pyruvate-utilizing biosynthetic pathway, e.g., pyruvate to acetolactate conversion. The invention also relates to methods of increasing the biosynthetic production of isobutanol, 2,3-butanediol, 2-butanol or 2-butanone using such host cells.
    Type: Application
    Filed: September 7, 2011
    Publication date: September 20, 2012
    Applicant: BUTAMAX(TM) ADVANCED BIOFUELS LLC
    Inventors: Larry Cameron Anthony, Lori Ann Maggio-Hall
  • Patent number: 8241878
    Abstract: Yeast strains were engineered that have increased activity of heterologous proteins that require binding of an Fe—S cluster for their activity. The yeast strains have reduced activity of an endogenous Fe—S protein. Activities of heterologous fungal or plant 2Fe-2S dihydroxy-acid dehydratases and Fe—S propanediol dehydratase reactivase were increased for increased production of products made using biosynthetic pathways including these enzymes, such as valine, isoleucine, leucine, pantothenic acid (vitamin B5), isobutanol, 2-butanone and 2-butanol.
    Type: Grant
    Filed: November 15, 2011
    Date of Patent: August 14, 2012
    Assignee: Butamax(TM) Advanced Biofuels LLC
    Inventors: Larry Cameron Anthony, Dennis Flint, Wonchul Suh, Rick W. Ye, Steven Cary Rothman, Jean-Francois Tomb
  • Publication number: 20120064585
    Abstract: Yeast strains were engineered that have increased activity of heterologous proteins that require binding of an Fe—S cluster for their activity. The yeast strains have reduced activity of an endogenous Fe—S protein. Activities of heterologous fungal or plant 2Fe-2S dihydroxy-acid dehydratases and Fe—S propanediol dehydratase reactivase were increased for increased production of products made using biosynthetic pathways including these enzymes, such as valine, isoleucine, leucine, pantothenic acid (vitamin B5), isobutanol, 2-butanone and 2-butanol.
    Type: Application
    Filed: November 15, 2011
    Publication date: March 15, 2012
    Applicant: BUTAMAXTM ADVANCED BIOFUELS LLC
    Inventors: Larry Cameron Anthony, Lori Ann Maggio-Hall, Steven Cary Rothman, Jean-Francois Tomb
  • Publication number: 20120015416
    Abstract: The invention relates to a recombinant host cell having (a) a modification in an endogenous polynucleotide encoding a polypeptide having dual-role hexokinase activity; (b) a heterologous polynucleotide encoding a polypeptide having hexose kinase activity; and optionally (c) a modification in an endogenous polynucleotide encoding a polypeptide having pyruvate decarboxylase activity. Additionally, the invention relates to methods of making and using such recombinant host cells including, for example, methods of increasing glucose consumption, methods of improving redox balance, and/or methods of increasing the production of a product of a pyruvate-utilizing pathway.
    Type: Application
    Filed: December 29, 2010
    Publication date: January 19, 2012
    Applicant: BUTAMAX(TM) ADVANCED BIOFUELS LLC
    Inventors: Larry Cameron Anthony, Arthur Leo Kruckeberg
  • Publication number: 20110124060
    Abstract: Crabtree positive yeast cells that have endogenous expressed pyruvate decarboxylase genes inactivated and an engineered biosynthetic pathway utilizing pyruvate were found to have improved growth and product yield when glucose repression was reduced. These cells were able to grow in media containing a high glucose concentration.
    Type: Application
    Filed: September 29, 2010
    Publication date: May 26, 2011
    Applicant: BUTAMAX(TM) ADVANCED BIOFUELS LLC
    Inventors: LARRY CAMERON ANTHONY, Mark J. Nelson
  • Publication number: 20100129887
    Abstract: Yeast cells with reduced activity of certain enzymes involved in branched chain amino acid biosynthesis in yeast mitochondria are described. Target enzymes include threonine deaminase, isopropylmalate synthase, and optionally branched chain amino acid transaminase.
    Type: Application
    Filed: November 12, 2009
    Publication date: May 27, 2010
    Applicant: BUTAMAX (TM) ADVANCED BIOFUELS LLC
    Inventor: Larry Cameron ANTHONY
  • Publication number: 20100129886
    Abstract: Yeast cells with modified expression of certain enzyme activities in the mitochondria are described for isobutanol production. Modifications described provide an isobutanol biosynthesis pathway in the yeast mitochondria.
    Type: Application
    Filed: November 12, 2009
    Publication date: May 27, 2010
    Applicant: BUTAMAX (TM) ADVANCED BIOFUELS LLC
    Inventors: Larry Cameron Anthony, Lixuan Lisa Huang, Rick W. Ye
  • Publication number: 20100120105
    Abstract: A microbial host cell is provided for the production of isobutanol. Carbon flux in the cell is optimized through the Entner-Doudoroff pathway.
    Type: Application
    Filed: October 27, 2009
    Publication date: May 13, 2010
    Applicant: BUTAMAX (TM) ADVANCED BIOFUELS LLC
    Inventors: Larry Cameron Anthony, Michael Dauner, Gail K. Donaldson, Brian James Paul
  • Publication number: 20100081179
    Abstract: Yeast strains were engineered that have increased activity of heterologous proteins that require binding of an Fe—S cluster for their activity. The yeast strains have reduced activity of an endogenous Fe—S protein. Activities of heterologous fungal or plant 2Fe-2S dihydroxy-acid dehydratases and Fe—S propanediol dehydratase reactivase were increased for increased production of products made using biosynthetic pathways including these enzymes, such as valine, isoleucine, leucine, pantothenic acid (vitamin B5), isobutanol, 2-butanone and 2-butanol.
    Type: Application
    Filed: September 29, 2009
    Publication date: April 1, 2010
    Applicant: BUTAMAX(TM) ADVANCED BIOFUELS LLC
    Inventors: LARRY CAMERON ANTHONY, Lori Ann Maggio-Hall, Steven Cary Rothman, Jean-Francois Tomb
  • Publication number: 20090305363
    Abstract: A high flux in conversion of pyruvate to acetolactate was achieved in yeast through expression of acetolactate synthase in the cytosol in conjunction with reduction in pyruvate decarboxylase activity. Additional manipulations to improve flux to acetolactate are reduced pyruvate dehydrogenase activity and reduced glycerol-3-phosphate dehydrogenase activity. Production of compounds having acetolactate as an upstream intermediate benefit from the increased conversion of pruvate to acetolactate in the described strains.
    Type: Application
    Filed: June 4, 2009
    Publication date: December 10, 2009
    Applicant: E. I. DU PONT DE NEMOURS AND COMPANY
    Inventors: Larry Cameron Anthony, Lori Ann Maggio-Hall